Home Medicine Sarcoidosis and its Relationship to Vitamin D
Chapter
Licensed
Unlicensed Requires Authentication

Sarcoidosis and its Relationship to Vitamin D

  • N. H. Bell , T. K. Sinha , P. H. Stern and H. F. DeLuca
© 2020 Walter de Gruyter GmbH, Berlin/Munich/Boston

© 2020 Walter de Gruyter GmbH, Berlin/Munich/Boston

Chapters in this book

  1. Frontmatter I
  2. Foreword V
  3. Contents VII
  4. List of Participants XIX
  5. Vitamin D-Chemistry
  6. 19-Hydroxy-IOS (19)-Dihydrovitamin D3 and 25-Hydroxy-24-norvitamin D3 : Analogs with Anti-Metabolite Activity and Related Studies 1
  7. Synthesis and Separation of C-24 Epimers of some 24-Hydroxylated Vitamin D3 Analogs 5
  8. The 'Overirradiation Products' of Previtamin D and Tachysterol: Toxisterols 15
  9. Conformational Analysis of Vitamin D and its Analogs by Ultraviolet, Circular Dichroic, 1H and 13C NMR Spectroscopy 19
  10. I,25-Dihydroxyvitamin D3 from Solanum Glaucophyllum 29
  11. Synthesis and Conformational Analysis of Vitamin D Metabolites and Analogs 33
  12. A Stereoselective Synthesis of la, 24R, 25-Trihydroxycholecalciferol, a Metabolite of Vitamin D3 47
  13. Crystal Structures and Empirical Force-Field Calculations of Some Steroids of the Vitamin D Series 57
  14. Approaches to the Synthesis of Vitamin D Metabolites and Analogs 61
  15. Conformational Analysis of Vitamin D: NMR and Force Field Calculations 71
  16. Vitamin D-Like Action of a Steroid from Trisetum Flavescens 85
  17. Vitamin D-Metabolism and Regulation
  18. Vitamin D3 Metabolism in Immature Japanese Quail: Effects of Ovarian Hormones 89
  19. Relationship of Intestinal Calcium and Phosphorus Absorption to Vitamin D Metabolism During Reproductive Activity of Birds 93
  20. On transcalciferin, the serum binding protein for 25-hydroxycholecalciferol 97
  21. Ultrastructural Alterations Produced by Vitamin D and its Metabolites on the Chick Parathyroid Gland 101
  22. Reduction of Parathyroid Hormone Secretion by 24, 25-Dihydroxy- Cholecalciferol (24, 25-DHCC) 105
  23. The Influence of Ca2+ Ions on the Metabolism of 25-Hydrcacy Cholecalciferol 109
  24. 1,25-Dihydroxyvitamin D3: Its Further Metabolism and the Regulation of its Biogenesis 113
  25. Disappearance from Plasma of Injected 3H-1,25- (OH)2-D3 in Healthy Humans 123
  26. Regulation of the Metabolism of 25(OH)D3: l,25(OH)2D3-Parathyroid Interactions 125
  27. Conversion of 7-Dehydrocholesterol to Vitamin D3 in Vivo: Isolation and Identification of Previtamin D3 from Skin 135
  28. Assessment of the Effects of 1,25-Dihydroxycholecalciferol (1,25-DHCC) on Parathyroid Secretion Rate in Calves 139
  29. Biological Activity of la,24-Dihydroxyvitamin D3; A New Synthetic Analog of the Hormonal Form of Vitamin D 143
  30. Metabolism of 1,25-Dihydroxyvitamin D3: Side Chain Oxidation in Vivo 147
  31. Calcium and Parathyroid Status in Normal Man Following Administration of 1,25-Dihydroxy-Vitamin D3 151
  32. Comparative Aspects of the Biochemistry of the Regulation of Vitamin D Metabolism 155
  33. Aspects of the Control of Vitamin D Metabolism in Man 165
  34. Metabolism of 25-Hydroxycholecalciferol by Various Lines of Serially Cultured Kidney Cells 175
  35. Metabolism of 25-hydroxyvitamin D3 and Iα-hydroxyvitamin D3 in experimental rats with chronic renal failure 179
  36. Modulation of 25-Hydroxyvitamin D3 Metabolism by Iα,25-Dihydroxyvitamin D3 183
  37. Circulating Iα,25-(OH)2D During Physiological States of Calcium 187
  38. Effect of Glucocorticoids on Vitamin D-Metabolism 191
  39. The Effects of Hypophysectomy on 25- Hydroxyvitamin D3 Metabolism in the Rat 197
  40. Regulation of the Metabolism of Vitamin D3 and 25-Hydroxyvitamin D3 201
  41. The Effect of Anticonvulsants on Rat Liver Calciferol 25-hydroxylase 211
  42. Sex Hormonal Control of the Renal Vitamin D Hydroxylases 215
  43. The Subcellular Localization of 1,25-Dihydroxyvitamin D3 in the Parathyroid Glands of Chickens 219
  44. Vitamin D-Intestinal Action
  45. The Dissociation of 1,25(OH)2D3-induced CaBP Production and Alkaline Phosphatase Activity from Calcium Transport by Actinomycin D and Cycloheximide 223
  46. Regulation of the Messenger RNA for Calcium Binding Protein by 1,25- Dihydroxycholecalciferol 227
  47. Cyclic AMP Regulation of the Iα,25-(OH)2D3-Mediated Intestinal Calcium Absorptive Mechanism 231
  48. A Modified Procedure for the Isolation of Chick Intestinal Calcium Binding Protein 241
  49. Chemical Studies on Bovine Intestinal Calcium Binding Protein and Related Peptides Minor A and Minor B 245
  50. The Effect of Vitamin D Activity on Rat Renal and Intestinal Calcium Binding Proteins 253
  51. Mechanism of Action of 1α,25-Dihydroxyvitamin D3 at the Intestine and Parathyroids 257
  52. 1,25-Dihydroxyvitamin D2: Characterization, Receptor Affinity and Biological Activity in the Chick 261
  53. Recent studies on 1,25-(OH)2D3 Action in the Intestine 265
  54. The Role of Phosphate in the Intestinal Response to Vitamin D 277
  55. Distribution of Alkaline Phosphatase and Ca-ATPase in Intestinal Epithelial Cell Plasma Membranes: Differential Response to 1,25-(OH)2D3 281
  56. The Relation between the Induction of Alkaline Phosphatase and 1,25-Dihydroxycholecalciferol Receptor in Chick Embryonic Duodenum 285
  57. Effects of Dietary Calcium and Phosphorus on the Steady State Levels of some Components of the Vitamin D Endocrine System 289
  58. Binding Components for Vitamin D3 Metabolites in Rat Intestine 299
  59. Light and Electron Microscopic Immunoperoxidase Localization of Chick Intestinal Vitamin D-Induced Calcium-Binding Protein 303
  60. The Effect of DDT on Vitamin D Metabolism and Calcium Binding Activity in the Chick 313
  61. Cytoplasmic Binding and Nuclear Uptake of Cholecalciferol Metabolites Inside Rat Duodenal Mucosa Cells 315
  62. Are the Cytosolic Binding Proteins for 25-Hydroxycholecalciferol Artifacts? 319
  63. Effects of Iα,25-Dihydroxyvitamin D3 on Active Intestinal Inorganic Phosphate Absorption 321
  64. Temporal Patterns of Response of the Intestinal Calcium Absorptive System and Related Parameters to 1,25-Dihydroxycholecalciferol 331
  65. Properties of Calcium and Magnesium Stimulated ATP'ase from Human Placenta 341
  66. The Effect of 1,25(OH)2D3 on Calcium Accumulation, Calcium Transport and Calcium Binding Protein in the Presence and Absence of Cycloheximide 345
  67. Vitamin D-Skeletal Action
  68. Effects of Vitamin D and its Metabolites on Bone 349
  69. Bone Cells as well as Bone Remodelling Surfaces in Renal Bone Disorders and Their Changes after Therapy — A Quantitative Analysis 359
  70. Localization of 3H-la,25-Dihydroxycholecalciferol in Rat Bone and Cartilage 369
  71. Vitamin D Dependent Bone Disease: Long-Term Responses to Vitamin D Analogs and Effect on Tetracycline Based Bone Dynamics 373
  72. The Dose-response Relationship of Tetracycline to the Detectability of Labeled Osteons by Fluorescence Microscopy 377
  73. Ultrastructural Studies of Bone - Influence of Vitamin D, PTH and Uremia on Bone Cell Ultrastructure and Bone Cell/Bone Matrix Interaction 381
  74. Multiple Isotope Indicator Studies of Bone Volume Changes in Rachitic and D Treated Rats 391
  75. Evaluation of a New Method for Studying Resorption by Isolated Bone Cells 395
  76. The effect of la-hydroxycholecalciferol on calcium balance and bone histology in a randomized trial 399
  77. The Effect of Vitamin D Steroles on Bone Histology in Incipient Renal Failure 407
  78. Action of Vitamin D Metabolites and Analogues, Parathyroid Hormone, Calcitonin and Steroid Sex Hormones on Bone in Tissue Culture 411
  79. Acid Phosphatase in Bone Cells from Vitamin D Deficient Rats 415
  80. Vitamin D — Renal Action
  81. The Effect of Vitamin D and its Metabolites on the Renal Handling of Phosphate 419
  82. Renal Handling of Calcium in Rats: Influence of Parathyroid Hormone and 1,25-Dihydroxyvitamin D3 433
  83. Adaptive Mechanisms to Phosphate Depletion: The Role of Vitamin D 437
  84. The Effect of Different Solanum Malacoxylon Extracts on Urinary Calcium Excretion in Vitamin D Deficient Rats 441
  85. Quantitative Effect and Pathogenic Mechanism of la-Hydroxy- Cholecalciferol on the Renal Handling of Phosphate 443
  86. Failure of Intravenous Calcium to Restore PTH-Induced Phosphaturia in Pseudohypoparathyroidism Type II. A Case Report 447
  87. Effects of Vitamin D on Renal Tubular Calcium Transport 451
  88. Vitamin D-Metabolite Assays
  89. Assay of Vitamin D3 (Cholecalciferol) in Plasma Using Gas Chromatography/ Selected Ion Monitoring (GC/SIM) 455
  90. Development of a Radioimmunoassay for Vitamin D 459
  91. Radioimmunoassay of Human Serum DBP, and Competitive Binding Protein Radioassay of 24,25-(OH)2D 463
  92. Radioligand Receptor Assay for 1,25-Dihydroxyvitamin D: Biochemical, Physiologic and Clinical Applications 473
  93. Evolution of vitamin D serum transport proteins 483
  94. Application of High Pressure Liquid Chromatography for Assay of Vitamin D Metabolites 491
  95. Intestinal Cytosol Binders for 1,25-Dihydroxyvitamin D3 : Use in a Competitive Binding Protein Assay 501
  96. Some Problems Associated with the Assay of 25-Hydroxycholecalciferol in Human Serum 511
  97. Influence of Extraction on Saturation Analysis of 25-Hydroxy- Vitamin D (25-OH-D) without prior Chromatography 515
  98. An Assay for 24, 25 and 25, 26 Dihydroxycholecalciferols in sera 519
  99. A "25-Hydroxycholecalciferol-Like Compound" in Milk as Determined by Specific Competitive Binding Radioassays 523
  100. Specific binding of 25-Hydroxycholecalciferol in Human Mammary cancer 527
  101. Bone Organ Culture Bioassay for Determination of 1,25-(0H)2D 531
  102. The Measurement of 24, 25-Dihydroxycholecalciferol in Human Serum 541
  103. Plasma 25 (OH) Vitamin D levels in Normal Subjects throughout the year and in Patients with Related Diseases 545
  104. Vitamin D-Nutritional Aspects
  105. Cholecalciferol Production 549
  106. Biological Activity Evaluation of Chemically Synthesized Vitamin D Metabolites and Analogs 553
  107. Dose-Response of 1,25-Dihydroxycholecalciferol on Serum Calcium and Phosphorus, Urine Electrolytes and Hydroxyproline Excretion in Dairy Cattle 565
  108. Biochemical Response to 1,25 (OH)2 Vitamin D Supplementation in Premature Infants: A Prospective Study 569
  109. Effects of Vitamin D on Tissue Exchangeable Zinc 573
  110. Parturient Paresis Prophylaxis with 25-Hydroxycholecalciferol 577
  111. Serum and Renal Histologic Changes in the Rat Following Adminstation of Toxic Amounts of 1,25-Dihydroxyvitamin D3 587
  112. Elevated 1,25-Dihydroxyvitamin D Levels in Plasma of Dairy Cows in Response to Parturient Hypocalcemia 591
  113. Environmental and Nutritional Influences on Plasma 25-Hydroxyvitamin D Concentration and Calcium Metabolism in Man 595
  114. Individual Differences in Susceptibility to Vitamin D-Induced Cardiovascular and Renal Damage: Need to Identify and Characterize its Toxic Metabolites 607
  115. Calcium Absorption and Calcium Balances in Man During Vitamin D Intake 611
  116. Potency of Natural and Artificial Ultra-Violet Irradiation as Determinants of Plasma 25-Hydroxyvitamin D in Man 615
  117. Biological Activity of 24R,25 and 24S,25-Dihydroxycholecalciferol (24R, 25 and 24S,25<OH)2D3) on Duodenal Calcium-Binding Protein (dCaBP) and Bone Calcium Mobilization in Rats 619
  118. I.25-Dihydroxyvitamin D3 and Jejunal Absorption of Calcium and Phosphate in Normal Subjects 623
  119. Vitamin D-Osteoporosis
  120. Vitamin D and Osteoporosis 627
  121. Long-Term Treatment of Osteoporotic Patients with 1α-OH-D3 and Calcium 635
  122. Evidence for Bihormonal Deficiency State (Estrogen and 1,25-Dihydroxyvitamin D) in Patients with Postmenopausal Osteoporosis 639
  123. Vitamin D-Renal Osteodystrophy
  124. 25 Hydroxyvitamin D in Renal Osteodystrophy: Results of a six-center Trial. Preliminary report 649
  125. Clincal Efficacy of 1,25-Dihydroxy-Vitamin D3 in Renal Osteodystrophy 657
  126. Comparison of l a Hydroxyvitamin D3 and 25 Hydroxyvitamin D3 in the Treatment of Renal Osteodystrophy. Greater Effect of 25 Hydroxyvitamin D3 in Mineralizing Bone 667
  127. Vitamin D, Osteomalacia, and Chronic Renal Failure 671
  128. Effects of 25 Hydroxycholecalciferol on Calcium Metabolism in Uremia 675
  129. The Effect of High Doses 5,6-Trans-25-Hydroxycholecalciferol on Calcium Metabolism in Relative Vitamin D Resistancy (Hypoparathyroidism and Chronic Renal Failure) 679
  130. Treatment of Renal Osteodystrophy in Children on Hemodialysis with Dihydrotachysterol (DHT) 681
  131. Growth and Bone Lesions in Experimental Uremia 685
  132. 1α-OH-D3 Induced Changes in Bone Related Parameters in Patients with Terminal Renal Failure before and after Kidney Transplantation 689
  133. Vitamin D-Other Clinical Topics
  134. The Effect of 1α Hydroxycholecalciferol on Secondary Hyperparathyroidism of Chronic Renal Failure 693
  135. 1α-Hydroxycholecalciferol and Phosphate Dialysis in Haemodialysis Osteodystrophy 697
  136. Clinical Efficacy of 5,6-Trans-25-OHCC in Chronic Renal Failure 701
  137. The Treatment of Renal Osteopathy with 5,6-Trans-25-OHCC. A Report of Experience made during a 32 months Therapy 715
  138. Vitamin D-Renal Osteodystrophy
  139. An Histologic Comparison of l,25(OH)2 Vitamin D Treatment with Calcium Supplementation in Renal Osteodystrophy 719
  140. Impaired l,25(OH)2D3 Production in Uremia in the Absence of Hyperphosphatemia or Kidney Damage 723
  141. Vitamin D-Other Clinical Topics
  142. Neonatal Hypocalcemia 727
  143. Hepatic Bioactivation of Vitamin D and Clinical Implications 737
  144. Sarcoidosis and its Relationship to Vitamin D 747
  145. Adult Vitamin-D Resistant Osteomalacia by Non Production of 25 OH-D 751
  146. Intestinal Absorption of Radiophosphate after Physiological Doses of 25(OH)D3 in Normals, Liver Cirrhosis and Chronic Renal Failure Patients 755
  147. Effects of Solanum Malacoxylon (SM) in Hypoparathyroidism 759
  148. Plasma Levels and Intestinal Absorption of 25-Hydroxyvitamin D after small Intestinal Resection 763
  149. Effect of Phenobarbital on Hepatic Vitamin D-25-Hydroxylase and Mixed Function Oxydases Activities in Vitro 767
  150. Vitamin D Resistant Rickets — Pathophysiology of the Various Syndromes 771
  151. The Effect of Phenobarbital (PB) Treatment on the Biliary Excretion of Cholecalciferol (D3) and 25-Hydroxy-Cholecalciferol (25-OHD3) in the D-Repleted Rat 781
  152. Effects of Metabolites and Analogues of Vitamin D3 in Hereditary Pseudo-Vitamin D Deficiency of Pigs 785
  153. Improvement of Fractional Intestinal 47Ca Absorption by 1,25-Dihydroxycholecalciferol in Patients on long-term Prednisone Treatment 789
  154. Biological Effects of 24,25-Dihydroxycholecalciferol in Man 793
  155. A Possible Mechanism for the Increased Urinary Calcium Excretion Induced by 1α Hydroxycholecalciferol Treatment to Hypoparathyroid Patients 797
  156. 25-Hydroxycholecalciferol Metabolism in Hepatobiliary Diseases 801
  157. Prophylactic Vitamin D Supplementation in Chronic Anticonvulsant Therapy 805
  158. The Treatment of Hypoparathyroidism with 25(OH)D3: Practical Conclusions and Metabolic Implications 809
  159. Plasma 250HD, Bone Mass Densitometry and 47Ca Intestinal Absorption Deficiency in Chronic Alcoholism 819
  160. Juvenile Rickets not Related to Vitamin D Deficiency 823
  161. 1,25-Dihydroxycholecalciferol: Oral Administration and Sterol Levels in the Long-Term Management of Idiopathic Hypoparathyroidism in Children 827
  162. Malabsorption of Vitamin D in Patients and Rat with Liver Cirrhosis 831
  163. Anticonvulsant Osteomalacia — An Overview 835
  164. 25-Hydroxyvitamin D Values in Chronic Liver Diseases and Response to Treatment with Parenteral Vitamin D 839
  165. 25-hydroxylation in chronic alcoholic liver disease 843
  166. Circulating 25-Hydroxyvitamin D Following Jejunal-Ileal Bypass 847
  167. Adult-Presenting Primary Hypophosphataemic Osteomalacia; Effects of Treatment with 1,25-Dihydroxycholecalciferol 851
  168. Influence of Vitamin D3 on Calcium Metabolism of the Newborn Infant 855
  169. Skeletal Mass and Serum Levels of 25-Hydroxyvitamin D in Postgastrectomy Patients 859
  170. Addendum
  171. Tumor Induced 1α,-25 Dihydroxycholecalciferol (1α,25-(OH)2D3) Deficiency: A Cause of Oncogenic Osteomalacia 863
  172. The Subcellular Distribution of 45Ca++-Effect of Warfarin/Antimycin A and Lanthanum 865
  173. Vitamin D and Pseudohypoparathyroidism 867
  174. Calcitonin load in patients with absorptive hypercalciuria 877
  175. Metabolism of 25-Hydroxyvitamin D3 (25-(OH)D3) in Primary Chick Kidney Cell Culture 879
  176. Bone Mineralisation and Plasma 25-OH Vitamin D in Chronic Renal Failure 883
  177. Histomorphometric Analysis of Trabecular Bone in Renal Dialysis Patients Treated with 25-Hydroxyvitamin D3: Preliminary Report 885
  178. Vitamin D Metabolites and Bone Mineralization In Man 897
  179. The Effect of la-OH-D3 Treatment on the Structure and Function of Chick Intestine Brush Border Membrane 913
  180. Solid-State Conformations of Vitamin D Molecules 927
  181. Fanconi Syndrome and its Relationship to Vitamin D 937
  182. Author Index 951
  183. Subject Index 959
  184. Backmatter 974
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/9783112327203-130/html?srsltid=AfmBOoqycIEE3Uj2NzY8l2YVi_Qsu-wNO9V3xPFqdq-vA7oaosmT84CL
Scroll to top button